Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.
Press releases published on April 15, 2025
EarthOptics Releases 2025 Predictive Ag Report, Helping Farmers Quantify Yield Risks and Optimize Planning
GlobeNewswire
·
April 15, 2025
MINNEAPOLIS, April 15, 2025 (GLOBE NEWSWIRE) -- Farmers across the Midwest have a powerful, updated tool to help with crop planning this season. The third annual Predictive Ag Report, released today by EarthOptics, a leader in soil analysis and crop …
LyondellBasell advances sustainability leadership in 2024 Sustainability Report: From Vision to Value
GlobeNewswire
·
April 15, 2025
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB), a global leader in the chemical industry, today released its 2024 Sustainability Report, demonstrating significant progress in circular and low-carbon solutions, climate action and …
Microchip Launches High-Reliability BR235 and BR235D Series of Power Relays for Demanding Military Applications
GlobeNewswire
·
April 15, 2025
CHANDLER, Ariz., April 15, 2025 (GLOBE NEWSWIRE) -- As a leading supplier to the aerospace and defense market, Microchip is committed to providing innovative and robust products that are designed for mission-critical performance in the most demanding …
Predictive Oncology Develops Novel Approach to Identifying Clinically Viable Abandoned Drugs
GlobeNewswire
·
April 15, 2025
New indications discovered by applying active machine learning and using samples from the company’s vast biobank of live-cell tumors specimens Builds upon Predictive’s biomarker discovery platform to select targeted patient cohorts to significantly de-risk …
Acronis Drives Cybersecurity Leadership with Over 7.5 Million Attacks Prevented, Continuous Growth, Innovation, and Industry Recognition
GlobeNewswire
·
April 15, 2025
SCHAFFHAUSEN, Switzerland, April 15, 2025 (GLOBE NEWSWIRE) -- Acronis, a global leader in cybersecurity and data protection, solidifies its position as a cybersecurity leader through significant milestones, a broadened global user base, and new product …
Neuphoria Provides a Review of 2024 and Highlights 2025 Plans
GlobeNewswire
·
April 15, 2025
Initiation by Merck of a Phase 2 trial in Alzheimer’s disease with partnered α7 nicotinic acetylcholine receptor PAM MK-1167 highlights company’s pipeline diversification beyond BNC210 US $15M milestone payment from Merck extends company’s cash runway to …
Basetwo Wins Top Prize at CIX Summit 2025, Selected for Startup World Cup
GlobeNewswire
·
April 15, 2025
TORONTO, April 15, 2025 (GLOBE NEWSWIRE) -- Basetwo, an AI platform for manufacturing, has been recognized at the 2025 CIX Summit as the 2025 Canadian Regional Winner, positioning itself to represent Canada at the upcoming Startup World Cup in Silicon …
Lisata Therapeutics Announces Research License with Catalent
GlobeNewswire
·
April 15, 2025
BASKING RIDGE, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other …
IPG Photonics to Announce First Quarter 2025 Financial Results on May 6
GlobeNewswire
·
April 15, 2025
MARLBOROUGH, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (Nasdaq: IPGP) will release its first quarter 2025 financial results before the market opens on Tuesday, May 6, 2025. The Company will hold a conference call to review these …
Rezolve Ai Secures $9.8 Million Annual Contract with Liverpool Mexico
GlobeNewswire
·
April 15, 2025
NEW YORK and MEXICO CITY, April 15, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), a global leader in AI-powered commerce technology, is proud to announce a landmark $9.8 million yearly contract with Liverpool Mexico, the country’s premier department …
ORYZON Announces First Patient Dosed in NCI-Sponsored Phase I/II Clinical Trial of Iadademstat Plus Immune Checkpoint Inhibitors in 1L Extensive Stage Small Cell Lung Cancer
GlobeNewswire
·
April 15, 2025
In combination with atezolizumab or durvalumab Study conducted under the CRADA agreement between NCI and Oryzon MADRID and CAMBRIDGE, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage …
Pipe Acquires Glean.ai to Add Spend Management to Suite of Embedded Financial Solutions
GlobeNewswire
·
April 15, 2025
SAN FRANCISCO, April 15, 2025 (GLOBE NEWSWIRE) -- Pipe, a fintech company enabling embedded financial solutions for software platforms, today announced its strategic acquisition of Glean.ai, a leading AI-powered spend management company. With this …
Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025
GlobeNewswire
·
April 15, 2025
HANOVER, Md., April 15, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies with improved efficacy and safety, …
LyondellBasell baut seine Führungsrolle im Bereich Nachhaltigkeit im Nachhaltigkeitsbericht 2024 aus: From Vision to Value (Von der Vision zum Wert)
GlobeNewswire
·
April 15, 2025
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB), ein weltweit führendes Unternehmen der chemischen Industrie, hat heute seinen Nachhaltigkeitsbericht 2024 veröffentlicht, in dem bedeutende Fortschritte bei zirkulären und …
LyondellBasell promueve el liderazgo en sostenibilidad en el Informe de Sostenibilidad 2024: De la visión al valor
GlobeNewswire
·
April 15, 2025
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB), un líder mundial en el sector de química, publicó hoy su Informe de Sostenibilidad 2024, que muestra un progreso significativo en soluciones circulares y bajas en carbono, acción …
RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development
GlobeNewswire
·
April 15, 2025
SOUTH SAN FRANCISCO, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living …
Combating Document Fraud and Transnational Crime: Lao PDR Airport Deploys Regula 4306 Comparator
GlobeNewswire
·
April 15, 2025
RESTON, Va., April 15, 2025 (GLOBE NEWSWIRE) -- The space-saving yet full-function video spectral comparator Regula 4306 has been deployed at Wattay International Airport in Vientiane, the Lao People’s Democratic Republic, to strengthen the country’s …
Mural Oncology Announces Plans to Explore Strategic Alternatives
GlobeNewswire
·
April 15, 2025
Following review of data from the phase 2 ARTISTRY-6 trial and previously announced results from the phase 3 ARTISTRY-7 trial, Mural will discontinue all clinical development of nemvaleukin With $144.4 million in cash as of December 31, 2024, Mural plans …
FluidForm Bio™ Advances Vascularized Tissue Engineering with New FRESH™ 3D Bioprinting Breakthrough
GlobeNewswire
·
April 15, 2025
WALTHAM, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced a major advancement in vascularized tissue engineering. A newly published study in ACS Biomaterials …
LyondellBasell renforce son leadership en matière de durabilité dans son Rapport sur le développement durable 2024 : From Vision to Value (De la vision à la valeur)
GlobeNewswire
·
April 15, 2025
HOUSTON, 15 avr. 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE : LYB), l’un des leaders mondiaux de l’industrie chimique, a publié aujourd’hui son Rapport sur le développement durable 2024, démontrant des progrès significatifs en matière de solutions …